Reference : Treatment of active rheumatoid arthritis with slow intravenous injections of thymopentin
Scientific journals : Article
Human health sciences : Rheumatology
http://hdl.handle.net/2268/94630
Treatment of active rheumatoid arthritis with slow intravenous injections of thymopentin
English
Malaise, Michel mailto [Université de Liège - ULiège > Département des sciences cliniques > Rhumatologie >]
Franchimont, P. [ > > ]
Bach-Andersen, R. [ > > ]
Gerber, H. [ > > ]
Stocker, H. [ > > ]
Hauwaert, Christian [Université de Liège - ULiège > > Rhumatologie >]
Danneskiold-Samsoe, B. [ > > ]
Gross, D. [ > > ]
Gerschpacher, H. [ > > ]
Bolla, K. [ > > ]
1985
Lancet
Lancet Publishing Group
13
1
832-836
Yes (verified by ORBi)
International
0140-6736
1474-547X
London
United Kingdom
[en] rheumatoid arthritis ; placebo-controlled double-blind randomised study ; thymopentin
[en] 41 patients with active rheumatoid arthritis entered a placebo-controlled double-blind randomised study in which 21 received slow intravenous injections (given in fractions over 10 min) of thymopentin (TP·5) 50 mg 3 times a week for 3 consecutive weeks and 20 received placebo in the same way. After 3 weeks of treatment the TP-5 group showed improvement (p<O' 05 or p<O: 01) in all but one of the clinical variables tested. There was improvement in the number of joints painful at rest, the number of joints painful on motion, scores for tenderness on pressure and swollen joints, severity of pain on awakening and morning stiffness, and right-hand grip strength; left hand grip strength remained unchanged. In the placebo group, only morning stiffness improved significantly.
Researchers ; Professionals
http://hdl.handle.net/2268/94630
10.1016/S0140-6736(85)92205-6

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Malaise_1985_Lancet_832-836.pdfPublisher postprint370.19 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.